Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma
Journal of Cancer Research and Therapeutics, vol.14, no.5, pp.1149-1151, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 14 Issue: 5
- Publication Date: 2018
- Doi Number: 10.4103/0973-1482.188293
- Journal Name: Journal of Cancer Research and Therapeutics
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1149-1151
- Keywords: Doxorubicin, durable response, insulinoma, pancreatic neuroendocrine tumors, short course, streptozotocin
- Trakya University Affiliated: Yes
Abstract
Due to the cytotoxic effects of old chemotherapy regimens used in the islet cell tumors, capecitabine plus temozolomide combination has now become the first choice in the treatment of malignant insulinoma (MIoma). We present this case to emphasize and remind that a durable complete response in advanced stage MIoma may be achieved with a short course of streptozotocin plus doxorubicin combination.